发明名称 SCREENING METHODS AND TRANSGENIC ANIMALS FOR TREATMENT OF BETA-GLOBIN RELATED DISEASES AND CONDITIONS
摘要 The orphan nuclear receptors TR2 and TR4 together constitute the DNA binding core of the 540 kDa DRED complex, a putative repressor of the human embryonic e- and fetal ?-globin genes. Here the functional consequences of TR2 and TR4 germ line loss of function were examined, transgenic gain of function and dominant negative gain of function on human and murine ß-type globin gene expression throughout development, e-globin transcription responded in a manner consistent with the hypothesis that TR2/TR4 is a constitutive erythroid e-globin repressor. In contrast, parallel experiments show that TR2/TR4 is a definitive stage-selective ?-globin repressor. This developmental stage-specific, gene-selective repression of the e- and ?-globin genes by TR2/TR4 establishes, when considered in concert with the competition hypothesis, a coherent molecular rationale for hemoglobin switching (temporally specific, sequential activation of all the ß-type globin genes) during vertebrate development.
申请公布号 WO2007140335(A2) 申请公布日期 2007.12.06
申请号 WO2007US69797 申请日期 2007.05.25
申请人 THE REGENTS OF THE UNIVERSITY OF MICHIGAN;ENGEL, JAMES, DOUGLAS 发明人 ENGEL, JAMES, DOUGLAS
分类号 C12Q1/68;G01N33/53 主分类号 C12Q1/68
代理机构 代理人
主权项
地址